Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 58.23
+3.05 (5.53%)
At close: Jul 31, 2026
SHE:301093 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 220.43 | 354.16 | 399.65 | 421.55 | 145.51 | 1,872 |
Short-Term Investments | - | 80.2 | 630.11 | 1,117 | 144.21 | - |
Trading Asset Securities | 962.66 | 845.32 | 268.93 | 40.91 | 1,379 | - |
Cash & Short-Term Investments | 1,183 | 1,280 | 1,299 | 1,580 | 1,669 | 1,872 |
Cash Growth | -4.87% | -1.46% | -17.80% | -5.31% | -10.88% | 3101.97% |
Accounts Receivable | 285.82 | 261.72 | 249.7 | 280.59 | 265.46 | 264.21 |
Other Receivables | 1.27 | 1.4 | 1.32 | 1.01 | 1.41 | 1.75 |
Receivables | 287.08 | 263.12 | 251.02 | 281.6 | 266.86 | 265.96 |
Inventory | 147.28 | 154.14 | 127.95 | 94.57 | 119.24 | 133.82 |
Other Current Assets | 32.83 | 9.73 | 16.89 | 16.36 | 25.88 | 17.48 |
Total Current Assets | 1,650 | 1,707 | 1,695 | 1,972 | 2,081 | 2,289 |
Property, Plant & Equipment | 655.98 | 647.3 | 584.46 | 546.32 | 387.05 | 273.89 |
Long-Term Investments | 61.36 | 33.14 | 37.47 | 37.04 | 25.5 | - |
Other Intangible Assets | 82.03 | 82.8 | 82.29 | 60.93 | 21.06 | 21.19 |
Long-Term Deferred Tax Assets | 14.21 | 13.18 | 10.99 | 8.35 | 4.26 | 2.29 |
Long-Term Deferred Charges | 21.23 | 21.86 | 18.91 | 25.82 | 31.84 | 29.14 |
Other Long-Term Assets | 45.79 | 47.03 | 76.09 | 60.63 | 29.88 | 17.02 |
Total Assets | 2,531 | 2,552 | 2,505 | 2,712 | 2,580 | 2,633 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 102.21 | 112.83 | 129.91 | 115.93 | 111.71 | 126.7 |
Accrued Expenses | 12.26 | 20.79 | 17.76 | 23.56 | 24.95 | 22.9 |
Short-Term Debt | - | - | - | - | - | 41.18 |
Current Portion of Long-Term Debt | 18.5 | 6 | - | - | - | - |
Current Portion of Leases | - | 1.41 | 0.6 | - | - | - |
Current Income Taxes Payable | 2.81 | 0.7 | 3.15 | 12.02 | 0.74 | 8.08 |
Current Unearned Revenue | 4 | 2.21 | 4.26 | 3.25 | 2.78 | 4.82 |
Other Current Liabilities | 35.57 | 42.4 | 16.77 | 16.85 | 5.17 | 9.43 |
Total Current Liabilities | 175.36 | 186.35 | 172.43 | 171.61 | 145.36 | 213.11 |
Long-Term Debt | 65.04 | 80.04 | - | - | - | - |
Long-Term Leases | - | 3.29 | 0.63 | - | - | - |
Long-Term Unearned Revenue | 48.81 | 24.77 | 22.2 | 21.67 | 13.64 | 3.4 |
Long-Term Deferred Tax Liabilities | 2.26 | 2.68 | 2.4 | 2.12 | 5.22 | - |
Other Long-Term Liabilities | 32.85 | 58.33 | 58.33 | 30 | - | - |
Total Liabilities | 324.31 | 355.47 | 255.99 | 225.4 | 164.21 | 216.51 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 164.2 | 164.2 | 127.08 | 135.79 | 134.67 | 134.67 |
Additional Paid-In Capital | 1,547 | 1,536 | 1,635 | 1,870 | 1,839 | 1,839 |
Retained Earnings | 527.27 | 526.66 | 491.75 | 519.79 | 442.6 | 443.11 |
Treasury Stock | -34.9 | -34.9 | -7.75 | -38.94 | - | - |
Comprehensive Income & Other | -0.08 | -0.05 | - | - | - | - |
Total Common Equity | 2,204 | 2,192 | 2,246 | 2,486 | 2,416 | 2,416 |
Minority Interest | 2.74 | 4.17 | 3 | - | - | - |
Shareholders' Equity | 2,207 | 2,197 | 2,249 | 2,486 | 2,416 | 2,416 |
Total Liabilities & Equity | 2,531 | 2,552 | 2,505 | 2,712 | 2,580 | 2,633 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 83.54 | 90.75 | 1.23 | - | - | 41.18 |
Net Cash (Debt) | 1,100 | 1,189 | 1,297 | 1,580 | 1,669 | 1,831 |
Net Cash Growth | -11.51% | -8.36% | -17.88% | -5.31% | -8.87% | - |
Net Cash Per Share | 5.26 | 5.58 | 6.00 | 6.87 | 7.33 | 10.16 |
Filing Date Shares Outstanding | 213.33 | 213.33 | 212.18 | 217.28 | 227.59 | 227.59 |
Total Common Shares Outstanding | 213.33 | 213.33 | 212.18 | 228.12 | 227.59 | 227.59 |
Working Capital | 1,475 | 1,520 | 1,522 | 1,801 | 1,935 | 2,076 |
Book Value Per Share | 10.33 | 10.28 | 10.58 | 10.90 | 10.62 | 10.62 |
Tangible Book Value | 2,122 | 2,110 | 2,163 | 2,425 | 2,395 | 2,395 |
Tangible Book Value Per Share | 9.95 | 9.89 | 10.20 | 10.63 | 10.52 | 10.52 |
Buildings | - | 411.76 | 285.7 | 282.41 | 252.99 | 252.99 |
Machinery | - | 663.71 | 519.98 | 478.95 | 332.88 | 304.21 |
Construction In Progress | - | 35.49 | 200.93 | 156.78 | 136.16 | 34.05 |